The association is basing its forecast on the 4.8% rise in healthcare costs per insured person in the first seven months of this year, it told the Keystone-SDA news agency. The figures were previously reported by Tamedia newspapers on Tuesday.
Santésuisse is also expecting strong cost growth next year, with tariff increases in favour of service providers on the cards.
According to a press release on Tuesday, comparison portal Bonus.ch meanwhile expects insurance premiums to rise even more sharply next year – by an average of almost 7%.
Health insurers with low reserves could even impose increases of over 12%, the website said. And “in the most extreme cases”, premiums could rise by more than 50%.
The costs for lab analyses, Spitex services and physiotherapy have notably been rising in recent times. In addition, drug costs as well as the amounts being prescribed have risen significantly, as have the volume of services, the number of treatments and administrative costs, according to Bonus.ch.
Adapted from German by DeepL/dos
More
More
Is there an answer to Switzerland’s spiralling healthcare cost misery?
This content was published on
Swiss residents must swallow a bitter pill of health insurance premiums rising by 8.7% next year. Is there a way out of this vicious circle?
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.